Lexeo Therapeutics, Inc. (LXEO)
6.29
+0.02
(+0.32%)
USD |
NASDAQ |
Feb 20, 16:00
6.25
-0.04
(-0.64%)
After-Hours: 20:00
Lexeo Therapeutics Shareholders Equity (Quarterly) : 120.83M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 81.54B |
| Insmed, Inc. | 738.98M |
| Eli Lilly & Co. | 26.54B |
| Madrigal Pharmaceuticals, Inc. | 602.69M |
| Phathom Pharmaceuticals, Inc. | -422.53M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 143.84M |
| Total Liabilities (Quarterly) | 23.01M |
| Debt to Equity Ratio | 0.07 |
| Current Ratio | 7.399 |
| Net Debt Paydown Yield | 0.22% |